AIDS Drug Assistance Programs Quickly Added Merck’s Isentress, Pfizer’s Selzentry, Despite Coverage Grace Period
This article was originally published in The Pink Sheet Daily
Executive Summary
Funding infusion, Medicare Part D helped ADAPs add new drugs and clear up patient waiting lists, according to report from Kaiser Foundation and state AIDS directors.
You may also be interested in...
Reanalyzed MERIT Data Suggests Selzentry Efficacy Matches HIV Standard Of Care
Enhanced Trofile assay reveals previous data included patients with HIV variants who should have been excluded, Pfizer and Monogram Biosciences report at ICAAC.
Reanalyzed MERIT Data Suggests Selzentry Efficacy Matches HIV Standard Of Care
Enhanced Trofile assay reveals previous data included patients with HIV variants who should have been excluded, Pfizer and Monogram Biosciences report at ICAAC.
Isentress Approval Carries Limited Indication
FDA follows lead of its September Antiviral Drugs Advisory Committee recommendation.